The Scotts Miracle Gro SMG posted Q3 earnings of $302.10 million, an increase from Q2 of 28.77%. Sales dropped to $1.61 billion, a 11.97% decrease between quarters. In Q2, The Scotts Miracle Gro earned $424.10 million, and total sales reached $1.83 billion.
Why ROCE Is Significant
Changes in earnings and sales indicate shifts in The Scotts Miracle Gro's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, The Scotts Miracle Gro posted an ROCE of 0.27%.
It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.
ROCE is an important metric for the comparison of similar companies. A relatively high ROCE shows The Scotts Miracle Gro is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and earnings per share growth.
In The Scotts Miracle Gro's case, the positive ROCE ratio will be something investors pay attention to before making long-term financial decisions.
Q3 Earnings Insight
The Scotts Miracle Gro reported Q3 earnings per share at $3.98/share, which beat analyst predictions of $3.39/share.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.